-
Pharmacology of Selected Opioids: classification
- Agonist: strong, mild-to-moderate
- Opioids with mixed actions: agonist-antagonist (Ag-Antag); partial agonist
- Antagonist: .
-
Strong agonists
- Morphine
- Heroin
- Hydromorphone (Dilaudid)
- Oxymorphone (Numorphan)
- Methadone (Dolophine)
- Meperidine (Demerol)
- Fentanyl (Sublimaze)
- Levorphanol (Levo-Dromoran)
-
Metabolism of heroin
- Heroin is biologically inactive
- In the body it is converted to MAM (monoacetylmorphine) and then to morphine: MAM and morphine are responsible for the effects elicited upon injection of heroin
-
Methadone (Dolophine)
- Mu agonist
- similar to morphine
- prolonged use fives rise to tolerance
- Oral efficacy!
-
Methadone (Dolophine): Uses
- relief of pain
- treatment of opioid abstinence syndrome
- treatment of opioid dependence
-
Opioid withdrawal syndrome
- within hours of missing first dose of morphine: sense of intense fear (can be alleviated by placebo)
- 8-16 hrs: lactation, rhinorrhea (as in a severe head cold), yawning, sweating, mydriasis, anorexia, nervousness, irritability, tremors, increased anxiety and fear, restless sleep
- within 36 hrs: skeletal muscle fasciculation and twitch, severe/painful cramps develop in legs and stomach
- intense/uncontrolled vomiting, salivation, diarrhea, and urination
- weakness, depression, chilliness/sweating, gooseflesh, muscle spasms, kicking movements
- patient is unable to sleep: increased respiratory rate, increased blood pressure, increased temperature, increased blood sugar, increased basal metabolic rate
- 48-72 hours: Reaches it's peak; subsides over net 10 days
- Withdrawal reaction: is evidence for physical dependence
-
Intensity of withdrawal reaction depends on
- half-life of drug being used: for morphine, with a short half-life, symptoms of abstinence are intense but brief
- for methadone, with a long-half-life, symptoms are less intense but more prolonged
- degree of physical dependency: withdrawal syndrome of methadone and codeine qualitatively the same but less intense than for morphine
-
Methadone
- Why is it used in treatment of opioid dependence?
- Methadone withdrawal is: *
- slower in onset
- longer in duration
- much less intense
- Why don't opioid addicts like it?
-
Differences in response to heroin and methadone
- methadone keeps plasma concentration in a narrow range
- but methadone has a wide range, get highs and lows
-
Meperidine (Demerol)
- does what morphine does, but - has a problem
- Mu-Agonist
- In equianalgesic doses produces as much sedation, respiratory depression, and euphoria as does morphine
- the rise in bile duct pressure - thought to be less than that caused by morphine
- constipation, urinary retention: less common than with morphine
-
Meperidine Toxicity
- can use it for a day or 2 but NOT for a week or 2
- Large, repeated doses can lead to an
- excitatory syndrome: hallucinations; tremors; muscle twitches; dilated pupils; hyper-reflexia; convulsions
- Due to the accumulation of normeperidine
- half time 15-20 house (meperidine = 3 hours)
- Not drug of choice for treatment of severe prolonged pain
-
Fentanyl
- Mu agonist
- 80 times more potent than morphine: as an analgesic
-
Uses of Fentanyl
- For anesthesia and post-op analgesia
- Duragesic: (transdermal patch) releases fentanyl over a period of 72 hours (for treatment of chronic pain; cancer pain)
- Patient controlled anesthesia (Actiq) - lollypop
-
Mild-to-moderate agonists
- Codeine
- Oxycodone (Oxycontin)
- Hydrocodone (Vicodin)
-
Propoxyphene - synthetic derivative, not very efficacious (Darvon)
- metabolizes to norpropoxyphene: 1/2 life ~30 hrs; accumulates and causes cardiotoxicity
- prolonged PR and QT intervals and widened QRS complex
-
Codeine
- high oral/parenteral ratio: partially protected from conjugation by the methyl group at C3
- Has very low affinity for opioid receptors
- Analgesic efficacy is due to its conversion to morphine: polymorphisms in cytochrome P450 isoform CYP2D6
- Dispensed alone or in combination with aspirin or acetaminophen
-
CYP3A4
very important enzyme in metabolizing drugs in the liver
-
Codeine and gene polymorphisms
- Caucasians (7%) - poor metabolizers
- Saudi Arabia, 20% , Ethiopia, 29% - Ultra-rapid metabolizers
-
Independent mechanisms of analgesia
- Hydrocodone: dispensed in combination with other drugs
- Acetaminophen - norcet, vicodin, lortab
- Ibuprofen - vicoprofen
- Oxycodone: Oxycontin - dispensed alone or in combination with
- Aspirin - percodan
- Acetaminophen - percocet
- Ibuprofen - combunox
-
Ototoxicity
- Rapid, progressive, and profound (> 83%) sensorineural hearing loss in patients taking Vicodin: successful rehabilitation with cochlear implants
- Hearing loss reported with propoxyphene
- Oxycodone (vicodin) gets concentrated in inner ear: when combine with other drugs, leads to hearing loss, tinnitus and 1st sigh of autotoxicity
-
Opioids with mixed actions: agonist-antagonist opioids
- substances that appear to be agonists at some receptors but antagonists at others: pentazocine; butorphanol
- Partial agonists: buprenorphine
-
Pentazocine
- intrinsic Mu antagonistic activity is sufficient to afford advantages over morphine as analgesic
- 20 mg -> decreased respiration = 10 mg morphine
- increased doses do not cause proportionate depression of respiration
- But high doses -> increased BP; increased HR
- Increased cardiac work in patients with coronary artery disease
- May precipitate withdrawal when given to Mu-opioid dependent individual
-
Pentazocine
- Talwin-NX (50mg Talwin + 0.5mg naloxone)
- Oral pill laced with naloxone, to prevent abuse potential through injection
- The added naloxone is degraded in liver
- If oral pill is powdered for injection naloxone produces aversive effects in individuals dependent on opioids
-
Ag-Antag Opioids
- Butorphanol (Stadol)
- More potent that morphine (on a per weight basis)
- 2-3mg -> 10mg morphine
- Onset, peak activity, duration ~ morphine
- lowest abuse potential
- Actions similar to pentazocine
- increased pulmonary arterial BP -> increases work of heart
- thus, less useful in patients with CHF or MI
-
Buprenorphine (Buprenex)
- on a per weight basis - better in longer duration of action: !
- Highly lipophilic opioid derivative of thebaine
- Partial Mu agonist; 25-50-fold more potent than morphine
- Produces analgesia and other CNS effects ~ to those of morphine
- Duration of analgesia is longer than that of morphine
-
Opioid antagonists
- Opioid antagonists produce few effects unless opioid agonists have been administered previously
- Naloxone
- Naltrexone
-
Naloxone: Clinical Use
In treatment of opioid toxicity, especially respiratory depression: In patients with respiratory depression small doses IM or IV promptly reverse effects of Mu opioid agonists in 1-2 minutes!
-
In diagnosis of physical dependence on opioids: IM small doses of naloxone precipitate moderate-to-severe withdrawal syndrome within minutes and subside in about 2 hours!!
-
Naltrexone
- Efficacious by the oral route
- Duration of action 24-48 hours
- Used in long-term management of opioid addiction
- the long duration of action serves as a safety valve after detoxification for patients with high motivation to remain opioid-free
- if a pt injects themselves with morphine or opioid, blocks the high of the drug..
|
|